Blog

Cancer in the Crosshairs: IMV Looks to Deliver Immunotherapy a New Way – Streetwise Reports


Streetwise Reports

Cancer in the Crosshairs: IMV Looks to Deliver Immunotherapy a New Way
Streetwise Reports
In this interview with The Life Sciences Report, IMV Inc.'s CEO Fred Ors and Pierre Labbè, chief financial officer, describe the innovative immunotherapy platform technology that has attracted partnerships with big pharma, prompted reorganization of ...

Flattr this!

2018-05-16 NEWS
About Michael Zand